Clinical Pharmacology and Therapeutics - Table of Contents alert Volume 93 Issue 1

Advertisement Myriad RBM's Comprehensive Protein Biomarker Solutions, helping turn biomarker studies into Biomarker Breakthroughs. From concept through clinical trial, Myriad RBM has the biomarkers, the platform and the expertise to guide your biomarker strategy. Click Here to learn more. TABLE OF CONTENTS Volume 93, Issue 1 (January 2013) In this issue In This Issue Editorial News & Views Perspectives Discovery & Development Regulation & Use State of the Art Errata & Corrigenda Also new AOP Sign up for CPT: Pharmacometrics & Systems Pharmacology e-alerts Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Web Focus: Induced Pluripotent Stem Cells Congratulations Dr. Shinya Yamanaka on winning the 2012 Nobel Prize in Physiology or Medicine for the discovery that mature cells can be reprogrammed to become pluripotent. Get to know the outstanding research of Dr. Yamanaka and his colleagues, in this dedicated web focus featuring a collection of their articles on iPS technology.   In This Issue Top In This Issue Clin Pharmacol Ther 2013 93: 1; 10.1038/clpt.2012.218 Full Text Editorial Top Information Hierarchies Optimize Patient-Centered Solutions S A Waldman and A Terzic Clin Pharmacol Ther 2013 93: 3-7; 10.1038/clpt.2012.208 Abstract | Full Text News & Views Top Highlights Clin Pharmacol Ther 2013 93: 8-9; 10.1038/clpt.2012.217 Full Text ASCPT News Clin Pharmacol Ther 2013 93: 10-16; 10.1038/clpt.2012.211 Full Text MACROSCOPY Global Networks of Excellence: Vehicles Fostering Therapeutic Innovation D Tancredi Clin Pharmacol Ther 2013 93: 17-19; 10.1038/clpt.2012.205 Full Text Perspectives Top COMMENTARY Personal Genomic Measurements: The Opportunity for Information Integration R B Altman Clin Pharmacol Ther 2013 93: 21-23; 10.1038/clpt.2012.203 Abstract | Full Text Discovery & Development Top TRANSLATION Partnering for Therapeutics Discovery C M Colvis, S Devaney, L S Brady and K L Hudson Clin Pharmacol Ther 2013 93: 24-25; advance online publication, November 28, 2012; 10.1038/clpt.2012.188 Full Text Developing New Drug Treatments in the Era of Network Medicine E K Silverman and J Loscalzo Clin Pharmacol Ther 2013 93: 26-28; advance online publication, October 15, 2012; 10.1038/clpt.2012.207 Full Text DEVELOPMENT Multimodal Dynamic Profiling of Healthy and Diseased States for Future Personalized Health Care G I Mias and M Snyder Clin Pharmacol Ther 2013 93: 29-32; advance online publication, October 12, 2012; 10.1038/clpt.2012.204 Full Text Regulation & Use Top PRACTICE Clinical Pharmacogenomics: Opportunities and Challenges at Point of Care S A Scott Clin Pharmacol Ther 2013 93: 33-35; advance online publication, December 5, 2012; 10.1038/clpt.2012.196 Full Text State of the Art Top Evolving Approaches of Hematopoietic Stem Cell–Based Therapies to Induce Tolerance to Organ Transplants: The Long Road to Tolerance J Leventhal, J Miller, M Abecassis, D J Tollerud and S T Ildstad Clin Pharmacol Ther 2013 93: 36-45; advance online publication, October 10, 2012; 10.1038/clpt.2012.201 Abstract | Full Text Prospects for Treatment of Latent HIV K M Barton, B D Burch, N Soriano-Sarabia and D M Margolis Clin Pharmacol Ther 2013 93: 46-56; advance online publication, October 10, 2012; 10.1038/clpt.2012.202 Abstract | Full Text The Role of Natriuretic Peptides as Biomarkers for Guiding the Management of Chronic Heart Failure S R Motiwala and J L Januzzi, Jr Clin Pharmacol Ther 2013 93: 57-67; advance online publication, November 28, 2012; 10.1038/clpt.2012.187 Abstract | Full Text New Avenues for Anticoagulation in Atrial Fibrillation S Mantha, K Cabral and J Ansell Clin Pharmacol Ther 2013 93: 68-77; advance online publication, December 5, 2012; 10.1038/clpt.2012.197 Abstract | Full Text Emerging Target-Based Paradigms to Prevent and Treat Migraine S D Silberstein Clin Pharmacol Ther 2013 93: 78-85; advance online publication, December 5, 2012; 10.1038/clpt.2012.198 Abstract | Full Text Longitudinal Cystic Fibrosis Care S S Antunovic, M Lukac and D Vujovic Clin Pharmacol Ther 2013 93: 86-97; advance online publication, November 14, 2012; 10.1038/clpt.2012.183 Abstract | Full Text Clinical Applications for microRNAs in Cancer S P Nana-Sinkam and C M Croce Clin Pharmacol Ther 2013 93: 98-104; advance online publication, December 5, 2012; 10.1038/clpt.2012.192 Abstract | Full Text Senescent Cells: A Novel Therapeutic Target for Aging and Age-Related Diseases R M Naylor, D J Baker and J M van Deursen Clin Pharmacol Ther 2013 93: 105-116; advance online publication, December 5, 2012; 10.1038/clpt.2012.193 Abstract | Full Text Computation as the Mechanistic Bridge Between Precision Medicine and Systems Therapeutics J Hansen and R Iyengar Clin Pharmacol Ther 2013 93: 117-128; advance online publication, December 5, 2012; 10.1038/clpt.2012.199 Abstract | Full Text Errata & Corrigenda Top ERRATUM Erratum: Population Imaging as Valuable Tool for Personalized Medicine Clin Pharmacol Ther 2013 93: 129; 10.1038/clpt.2012.212 Full Text CORRIGENDUM Corrigendum: Compartment-Specific Gene Regulation of the Car Inducer Efavirenz In Vivo Clin Pharmacol Ther 2013 93: 129; 10.1038/clpt.2012.213 Full Text Advertisement Congratulations to Shinya Yamanaka on winning the 2012 Nobel Prize in Physiology or Medicine for the discovery that mature cells can be reprogrammed to become pluripotent. Get to know his research by reading his outstanding State of the Art contribution to Clinical Pharmacology & Therapeutics on the use of induced pluripotent stem cells in drug development.   Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.